Caenorhabditis elegans as a model system for Parkinson's disease

被引:30
|
作者
Schmidt, Enrico
Seifert, Mark
Baumeister, Ralf
机构
[1] Univ Freiburg, Bioinformat & Mol Genet Fac Biol, Ctr Biochem & Mol Cell Res, Fac Med, DE-79104 Freiburg, Germany
[2] Univ Freiburg, Freiburg Ctr Syst Biol, ZBSA, DE-79104 Freiburg, Germany
关键词
Caenorhabditis elegans; dopaminergic system; Parkinson's disease; endoplasmic reticulum stress; oxidative stress;
D O I
10.1159/000101845
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is one of the most common age-related neuroclegenerative diseases that is characterized by selective loss of dopaminergic neurons. Despite recent findings from mammalian model systems, molecular mechanisms of the pathophysiology are poorly understood. Given the high conservation of molecular pathways from invertebrates to mammalians, combined with technical advantages, such as high-throughput approaches, Caenorhabditis elegans represents a powerful system for the identification of factors involved in neurodegeneration. In this review we describe that C elegans can be used to advance our understanding of the genetic mechanisms implicated in these disorders.
引用
收藏
页码:199 / 217
页数:19
相关论文
共 50 条
  • [31] LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
    Yao, Chen
    El Khoury, Rabih
    Wang, Wen
    Byrd, Tara A.
    Pehek, Elizabeth A.
    Thacker, Colin
    Zhu, Xiongwei
    Smith, Mark A.
    Wilson-Delfosse, Amy L.
    Chen, Shu G.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 73 - 81
  • [32] SERCA inhibition improves lifespan and healthspan in a chemical model of Parkinson disease in Caenorhabditis elegans
    Romero-Sanz, Silvia
    Caldero-Escudero, Elena
    Alvarez-Illera, Pilar
    Santo-Domingo, Jaime
    Fonteriz, Rosalba I. I.
    Montero, Mayte
    Alvarez, Javier
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [33] Caenorhabditis elegans in Parkinson's Disease Drug Discovery: Addressing an Unmet Medical Need
    Nass, Richard
    Merchant, Kalpana M.
    Ryan, Timothy
    MOLECULAR INTERVENTIONS, 2008, 8 (06) : 284 - 293
  • [34] Synthesis of Melatonin Derivatives and the Neuroprotective Effects on Parkinson's Disease Models of Caenorhabditis elegans
    He, Li
    Du, Jing-Jing
    Zhou, Jun-Jie
    Chen, Meng-Ting
    Luo, Lu
    Li, Bao-Qiong
    Zhang, Xiang-Zhi
    Ma, Wen-Zhe
    Ma, Ai-Jun
    Feng, Na
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [35] Lycium barbarum glycopetide prolong lifespan and alleviate Parkinson's disease in Caenorhabditis elegans
    Zheng, Jingming
    Luo, Zhenhuan
    Chiu, Kin
    Li, Yimin
    Yang, Jing
    Zhou, Qinghua
    So, Kwok-Fai
    Wan, Qin-Li
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [36] Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease
    Tsai, Chia-Wen
    Tsai, Rong-Tzong
    Liu, Shih-Ping
    Chen, Chang-Shi
    Tsai, Min-Chen
    Chien, Shao-Hsuan
    Hung, Huey-Shan
    Lin, Shinn-Zong
    Shyu, Woei-Cherng
    Fu, Ru-Huei
    CELL TRANSPLANTATION, 2017, 26 (12) : 1903 - 1918
  • [37] Reserpine ameliorates Aβ toxicity in the Alzheimer's disease model in Caenorhabditis elegans
    Arya, Upasna
    Dwivedi, Hemalata
    Subramaniam, Jamuna R.
    EXPERIMENTAL GERONTOLOGY, 2009, 44 (6-7) : 462 - 466
  • [38] Caenorhabditis elegans as a model system for human diseases
    Markaki, Maria
    Tavernarakis, Nektarios
    CURRENT OPINION IN BIOTECHNOLOGY, 2020, 63 : 118 - 125
  • [39] A Caenorhabditis elegans Model System for Amylopathy Study
    Duan, Zhibing
    Sesti, Federico
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (75):
  • [40] Modeling Alzheimer's Disease in Caenorhabditis elegans
    Alvarez, Javier
    Alvarez-Illera, Pilar
    Santo-Domingo, Jaime
    Fonteriz, Rosalba I.
    Montero, Mayte
    BIOMEDICINES, 2022, 10 (02)